[Key epidemiological data and recommended prevention and control measures for primary liver cancer]. [PDF]
Zhonghua Gan Zang Bing Za ZhiCao GW.
europepmc +1 more source
[Construction of a highly efficient HBV infection cell model based on HBV co-receptor neuropilin-1]. [PDF]
Zhonghua Gan Zang Bing Za ZhiLiu ZH, He XM, Xu KX, Yu HB, Chen J.
europepmc +1 more source
[The partial cure represents an intermediate endpoint on the path to a functional cure, not an ideal endpoint]. [PDF]
Zhonghua Gan Zang Bing Za ZhiZhuang H.
europepmc +1 more source
[Semaglutide-induced acute-on-chronic liver failure: A case report and literature review]. [PDF]
Zhong Nan Da Xue Xue Bao Yi Xue BanFu R, Wu H, Huang H, Sun B.
europepmc +1 more source
[Analysis of the prevalence status and clinical characteristics of the hepatitis D virus in the Xinjiang region]. [PDF]
Zhonghua Gan Zang Bing Za ZhiWang ZG +14 more
europepmc +1 more source
[Transitional and clinical practice pathways for whole-course management of hepatocellular carcinoma in the infectious diseases department]. [PDF]
Zhonghua Gan Zang Bing Za ZhiTao YC +5 more
europepmc +1 more source
[Clinical research advances for small-molecule nucleic acid drugs in the treatment of chronic hepatitis B]. [PDF]
Zhonghua Gan Zang Bing Za ZhiWang WX +4 more
europepmc +1 more source
[Introduction to the update points of the 2025 European Association for the Study of Liver clinical practice guidelines for the management of chronic hepatitis B infection]. [PDF]
Zhonghua Gan Zang Bing Za ZhiZhuang H.
europepmc +1 more source
[Differences in the mechanisms, diagnostic biomarkers, and therapeutic strategies of drug-induced liver injury caused by traditional Chinese and Western medicines]. [PDF]
Zhong Nan Da Xue Xue Bao Yi Xue BanZhu J +6 more
europepmc +1 more source
[Chinese expert consensus on clinical practice of chronic hepatitis B functional (clinical) cure]. [PDF]
Zhonghua Gan Zang Bing Za ZhiAuthor Group of Expert Consensus.
europepmc +1 more source